USD 1.09
(-5.22%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -8.92 Million USD | 118.45% |
2022 | -3.94 Million USD | -217.54% |
2021 | -1.3 Million USD | 678.11% |
2020 | -2.3 Million USD | -19.02% |
2019 | -2.37 Million USD | -383.12% |
2018 | -491.79 Thousand USD | -248.4% |
2017 | -141.15 Thousand USD | 71.02% |
2016 | -487.14 Thousand USD | -63.95% |
2015 | -290.93 Thousand USD | -311.04% |
2014 | -72.28 Thousand USD | 13.49% |
2013 | -83.55 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -432.37 Thousand USD | 43.19% |
2024 Q2 | -676.79 Thousand USD | 86.0% |
2023 Q1 | -4.61 Million USD | -127.22% |
2023 FY | - USD | 118.45% |
2023 Q4 | 1.47 Million USD | 288.06% |
2023 Q3 | -782.52 Thousand USD | 28.06% |
2023 Q2 | -1.08 Million USD | 76.44% |
2022 Q3 | -8.72 Million USD | 36.89% |
2022 Q4 | 16.96 Million USD | 294.5% |
2022 FY | - USD | -217.54% |
2022 Q1 | -13.63 Million USD | -4028.09% |
2022 Q2 | -13.82 Million USD | -1.36% |
2021 Q2 | -735.42 Thousand USD | -310.46% |
2021 FY | - USD | 678.11% |
2021 Q4 | -330.33 Thousand USD | -277.62% |
2021 Q3 | -87.47 Thousand USD | 88.1% |
2021 Q1 | -179.16 Thousand USD | 54.87% |
2020 Q1 | -478.42 Thousand USD | 61.85% |
2020 Q3 | -747.28 Thousand USD | -7.31% |
2020 Q2 | -696.35 Thousand USD | -45.55% |
2020 FY | - USD | -19.02% |
2020 Q4 | -397.01 Thousand USD | 46.87% |
2019 Q3 | -250.83 Thousand USD | -1.29% |
2019 Q1 | -617.3 Thousand USD | 0.0% |
2019 FY | - USD | -383.12% |
2019 Q4 | -1.25 Million USD | -399.9% |
2019 Q2 | -247.65 Thousand USD | 59.88% |
2018 Q2 | -839.06 Thousand USD | -1887.98% |
2018 Q1 | -42.2 Thousand USD | 13.85% |
2018 FY | - USD | -248.4% |
2017 Q4 | -48.99 Thousand USD | 23.34% |
2017 FY | - USD | 71.02% |
2017 Q3 | -63.9 Thousand USD | -4.04% |
2017 Q2 | -61.42 Thousand USD | -150.12% |
2017 Q1 | 122.54 Thousand USD | -26.73% |
2016 Q1 | -337.8 Thousand USD | -390.3% |
2016 Q2 | -13.77 Thousand USD | 95.92% |
2016 Q4 | 167.25 Thousand USD | 350.87% |
2016 Q3 | -66.67 Thousand USD | -384.03% |
2016 FY | - USD | -63.95% |
2015 Q4 | -68.89 Thousand USD | -316.28% |
2015 FY | - USD | -311.04% |
2015 Q2 | -77.54 Thousand USD | 59.53% |
2015 Q1 | -191.6 Thousand USD | -1576.06% |
2015 Q3 | -16.55 Thousand USD | 78.66% |
2014 Q1 | -64.58 Thousand USD | -971.0% |
2014 Q4 | -11.43 Thousand USD | -129.83% |
2014 FY | - USD | 13.49% |
2014 Q3 | 38.32 Thousand USD | 2734.32% |
2014 Q2 | 1352.00 USD | 102.09% |
2013 Q1 | -16.08 Thousand USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q3 | -60.38 Thousand USD | -347.29% |
2013 Q4 | -6030.00 USD | 90.01% |
2013 Q2 | -13.5 Thousand USD | 16.06% |
Name | EBITDA | EBITDA Difference |
---|---|---|
CorVel Corporation | 121.35 Million USD | 107.352% |
eHealth, Inc. | -9.15 Million USD | 2.574% |
Erie Indemnity Company | 568.01 Million USD | 101.571% |
GoHealth, Inc. | 24.1 Million USD | 137.016% |
Reliance Global Group, Inc. | -8.92 Million USD | -0.0% |
Tian Ruixiang Holdings Ltd | -2.93 Million USD | -203.833% |
Willis Towers Watson Public Limited Company | 2.33 Billion USD | 100.382% |